Every year, over 9 million new cases of TB are reported worldwide, with almost 2 million deaths. To make matters worse, the threat of multidrug-resistant bacilli has emerged, making the disease more expensive and difficult to treat.
In 2010, the World Health Organization (WHO) reported an unexpectedly high prevalence of multidrug-resistant tuberculosis with peaks of 25% or more among new cases of TB in some settings. At present, an estimated 5% of the more than 9 million people who develop TB around the world every year are infected with an MDR-TB strain, i.e. a strain that is resistant to (at least) the two most powerful anti-TB drugs currently available, isoniazid and rifampicin.
During a joint press conference at the 20th Annual Congress of the European Respiratory Society, experts in the field of tuberculosis will address current challenges in the management of the disease, such as TB/HIV co-infection and the rise of resistant TB strains as well as present an European TB research network, TBNET, aimed at advancing science, clinical research, training, policy development and public health.
“TB is a global problem that needs to be dealt with by the international community,” urges Professor Giovanni Battista Migliori, ERS Assembly Head of Respiratory Infections and Director of the WHO Collaborating Centre for TB and Lung Disease, Tradate, Italy.
TBNET is an ERS-supported Clinical Research Collaboration (CRC) in the area of tuberculosis research, working in close collaboration with WHO and ECDC. The main areas of focus are the development of improved diagnostic methods and new drugs as well as the prevention and control of drug-resistant TB.
“One of the biggest problems in most European countries is that treatment success rates are far below the 85% target set by the WHO World Health Assembly, thereby promoting resistance to common anti-tuberculosis drugs” explains Dr Davide Manissero, Head of Section Respiratory Tract Infections and Tuberculosis Programme Coordinator at the ECDC, Stockholm, Sweden.
“Part of the problem is that treatment for multidrug-resistant TB takes substantially longer than for uncomplicated TB; treatment of MDR requires up to 24 months` worth of treatment. The drugs needed are less effective than the first-line drugs for the treatment of drug-susceptible TB and cause more side effects,” says Dr Manissero.For multidrug-resistant TB, the treatment success rate is extremely low (31%).
The M/XDR-TB threat is further aggravated by the poor outcomes of this group of patients. In a cohort of 1,100 patients only 30.9% of those who started treatment in 2006 (2006 cohort) were successfully treated in the EU/EEA. A high percentage (13.2%) of these MDR-TB cases defaulted from treatment, increasing the risk for XDR-TB.
The latest figures on multidrug-resistant tuberculosis show about 440,000 cases of MDR-TB, causing at least 150,000 deaths. XDR-TB has been reported officially from 58 countries as of March 2010, explains Professor Mario Raviglione, Director, Stop TB Department, WHO, Geneva. “Of all cases of TB, over a million occurred among people living with HIV/AIDS and nearly half a million were fatal.”
It is unclear whether HIV infection is a risk factor for drug-resistant or MDR-TB. Known factors that can promote the development of resistance include malabsorption, drug intolerance, drug interactions, and noncompliance among intravenous drug abusers.
Dr Raviglione concludes: “Proper TB control based on early and rapid detection and adequate treatment until cure must be in place everywhere to interrupt transmission, avert deaths, and prevent MDR-TB.”
Dr. Anka Stegmeier-Petroianu | idw
Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University
Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
23.08.2017 | Life Sciences
23.08.2017 | Life Sciences
23.08.2017 | Physics and Astronomy